| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830251112 |
| P698 | PubMed publication ID | 7489744 |
| P2093 | author name string | Hirose S | |
| Okumura K | |||
| Shirai T | |||
| Abe M | |||
| Nakajima A | |||
| Azuma M | |||
| Yagita H | |||
| Terashi A | |||
| Kodera S | |||
| Nuriya S | |||
| P2860 | cites work | Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation | Q24311763 |
| CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones | Q28209894 | ||
| Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells | Q71714749 | ||
| CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro | Q71785810 | ||
| The role of the CD28 receptor during T cell responses to antigen | Q28263234 | ||
| A new member of the immunoglobulin superfamily--CTLA-4 | Q28299244 | ||
| Differential T cell costimulatory requirements in CD28-deficient mice | Q28590647 | ||
| TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
| CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines | Q33838538 | ||
| Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule | Q34298838 | ||
| Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation | Q34591923 | ||
| CTLA4 mediates antigen-specific apoptosis of human T cells | Q34735857 | ||
| Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia | Q35320964 | ||
| CTLA-4 is a second receptor for the B cell activation antigen B7 | Q36230356 | ||
| Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes | Q36232150 | ||
| Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. | Q36349869 | ||
| Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis | Q36352584 | ||
| Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo | Q36362877 | ||
| CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite | Q36363477 | ||
| The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro | Q36363984 | ||
| B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells | Q36364036 | ||
| Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse | Q36364541 | ||
| CD5+ B cells in autoimmune disease and lymphoid malignancy | Q36636718 | ||
| Expression and functional significance of an additional ligand for CTLA-4. | Q36687418 | ||
| Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation | Q36687697 | ||
| B70 antigen is a second ligand for CTLA-4 and CD28 | Q36697598 | ||
| T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo | Q37308435 | ||
| Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy | Q38624477 | ||
| CD5 B cells, a fetal B cell lineage | Q40386272 | ||
| B-cell and T-cell function in systemic lupus erythematosus | Q40490331 | ||
| CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. | Q41517114 | ||
| Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production | Q41853080 | ||
| Functional expression of B7/BB1 on activated T lymphocytes | Q41898118 | ||
| B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy | Q42675165 | ||
| B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. | Q42828319 | ||
| Treatment of murine lupus with CTLA4Ig | Q46538983 | ||
| Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses | Q56909495 | ||
| Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg | Q56909899 | ||
| Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo | Q59082223 | ||
| A cell culture model for T lymphocyte clonal anergy | Q67299314 | ||
| Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway | Q69342057 | ||
| Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice | Q70259590 | ||
| Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production | Q70338857 | ||
| Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation | Q71671790 | ||
| A negative regulatory function of B7 revealed in B7-1 transgenic mice | Q71678875 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 3060-3069 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule | |
| P478 | volume | 25 |
| Q40025850 | Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance |
| Q33746862 | Anti-DNA autoantibodies and systemic lupus erythematosus |
| Q33329462 | Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression |
| Q77737320 | B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity |
| Q46346021 | B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse |
| Q56908828 | CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes |
| Q71930311 | CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus |
| Q41936423 | CD80 costimulation is essential for the induction of airway eosinophilia |
| Q38045307 | Coinhibitory molecules in autoimmune diseases. |
| Q47913418 | Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus |
| Q41312371 | Costimulation and autoimmunity |
| Q56907492 | Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells |
| Q74417602 | Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis |
| Q43634784 | Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease |
| Q77976652 | Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3 |
| Q35795846 | Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. |
| Q58598629 | HSV-1 ICP22 suppresses CD80 expression by murine dendritic cells |
| Q41074347 | Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells |
| Q74340572 | Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis |
| Q73438336 | Involvement of Fas and Fas ligand interaction in allogeneic hepatocyte rejection in the spleen |
| Q44655245 | Langerhans’ cells in the murine oral mucosa in the inductive phase of delayed type hypersensitivity with 1-chloro-2, 4-dinitrobenzene |
| Q34397059 | Lupus autoantigens: their origins, forms, and presentation |
| Q36732041 | Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation |
| Q35919783 | Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway |
| Q35925037 | Role of CD28 in fatal autoimmune disorder in scurfy mice |
| Q78951897 | Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL) |
| Q77151802 | Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD) |
| Q74616747 | T cell-mediated effector mechanisms in the rejection of allogeneically transplanted hepatocytes |
| Q34108813 | T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules |
| Q42525230 | The Th2-response in mercuric chloride-induced autoimmunity requires continuing costimulation via CD28. |
| Q79236386 | The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis |
| Q73348120 | Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response |
Search more.